Peptide therapy TikTok claims: what the science actually supports

What did @karysamccall actually say?

The creator describes a morning peptide stack of three compounds: GHK-Cu for "skin and healing support," BPC-157 for "recovery support," and SS-31 for "energy support." She pairs these with water, sunlight, protein, and movement, and is careful to say she's "way less interested in miracle claims" and more focused on long-term wellness. That framing matters.

She doesn't assign specific mechanisms, doesn't cite dosing, and doesn't claim any of these peptides treat a disease. The emotional core of the video is about confidence, self-care, and feeling good internally. As far as TikTok peptide content goes, this is on the more restrained end of the spectrum. But "restrained" doesn't mean scientifically settled, and three of these compounds carry very different evidence profiles that are worth pulling apart.

Does the science back this up?

Partially, but the evidence quality varies dramatically across all three compounds. GHK-Cu has the most human-relevant data. BPC-157 has promising animal data and almost no human trials. SS-31 is the most experimental of the three, with most evidence confined to lab and animal models.

GHK-Cu (copper peptide) has been studied in skin aging contexts with some legitimate findings. Gorouhi and Maibach (2009, International Journal of Cosmetic Science) reviewed evidence showing GHK-Cu can stimulate collagen synthesis and wound healing in vitro and in some human studies. That supports a loose "skin and healing support" framing, though topical and injectable GHK-Cu are very different delivery contexts.

BPC-157 is derived from a gastric protein and has shown regenerative effects on tendons, gut tissue, and muscle in rodent models (Seiwerth et al., 2014, Current Pharmaceutical Design). But there are no peer-reviewed human randomized controlled trials published to date. Calling it "recovery support" is technically a soft enough claim that it's hard to falsify, which is both its defense and its problem.

SS-31 (elamipretide) targets mitochondrial cardiolipin and has shown results in animal aging and cardiac models. Szeto (2014, Antioxidants and Redox Signaling) documented mitochondrial protective effects. Human trials exist in heart failure populations, not healthy optimization users. "Energy support" is a speculative leap for a general wellness context.

What did they get wrong (or right)?

She got the framing mostly right. Saying she's "way less interested in miracle claims" while acknowledging these support lifestyle fundamentals is exactly the kind of epistemic humility missing from most peptide content online. That deserves credit.

What she got wrong, or at least incomplete, is the implicit suggestion that these three compounds have comparable evidence bases. They don't. GHK-Cu has the most defensible skin-adjacent data. BPC-157 is plausible but unproven in humans. SS-31 for "energy support" in a healthy adult is genuinely speculative territory. Grouping them as a tidy morning stack without acknowledging those gaps is a soft form of false equivalence.

The "energy support" framing for SS-31 is the weakest link here. Mitochondrial function and subjective energy are connected concepts, but the mechanistic leap from lab data to "this gives me energy" is not established in healthy populations. That's worth flagging plainly.

What should you actually know?

If you're curious about any of these compounds, the honest answer is that two of them (BPC-157 and SS-31) lack the human trial data needed to make confident wellness claims. That doesn't mean they're dangerous or useless. It means the evidence isn't there yet to know.

GHK-Cu has a longer research track record, particularly in wound healing and skin applications, and some of the topical data is reasonably solid. Injectable GHK-Cu is a different question entirely. Delivery method changes everything about bioavailability and effect.

On the regulatory side: BPC-157 is not FDA-approved. SS-31 (elamipretide) has an FDA orphan drug designation for Barth syndrome but is not approved for general wellness use. GHK-Cu is used in cosmetic products legally, but injectable versions exist in a compounded peptide gray zone. Anyone using these compounds should be working with a licensed provider who can assess individual health context, not building a stack from a TikTok video.

The lifestyle pillars she mentions, water, sunlight, protein, and movement, have far stronger evidence bases than any of these peptides. If those are already optimized and a provider recommends a peptide as an adjunct, that's a different conversation than starting here.